A Holistic Approach to Precision Medicine with Zhengming Chen

Aug 7, 2023

Share

In this testimony, Zhengming Chen discusses a holistic approach to understanding health, disease control, and prevention. He emphasizes the importance of precision medicine, studying diverse populations, and the potential for international collaboration.

A Holistic Approach to Precision Medicine

Precision medicine involves not only precise and individualized treatment but also risk prediction, prevention, and pre-emptive measures. Zhengming highlights the importance of studying healthy individuals to understand the real etiological effects of various factors.

Cohort Studies and Diverse Populations

Cohort studies allow simultaneous study of several thousand diseases, understanding their individual etiology, and identifying common risk factors. Studying diverse populations, considering genetic architectures, lifestyle factors, and disease incidence rates, is crucial.

Private-Public Partnerships

Turning samples into data on a large scale requires collaboration between private and public sectors. This partnership can accelerate funding, resources, expertise, and translational applications.

The Future of Precision Medicine

Zhengming sees the current stage as the beginning of a quiet but fundamental development phase. Building larger biobank studies and applying high-throughput genomic technologies will lead to understanding etiology, identifying drug targets, and personalized treatment. He expresses optimism and eagerness to continue involvement in this field.

Conclusion

Zhengming Chen's testimony provides a comprehensive view of the future of precision medicine. His insights into cohort studies, the importance of diverse populations, and the potential for collaboration paint a promising picture for personalized healthcare.About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

Precision Medicine Innovations

Cohort Study Insights

International Healthcare Collaboration

Genomic Research Advancements

Holistic Health Approaches

Share this article :

Share

More Testimonies

Pioneering a Revolution in Genomic Research: MGI Partners with Xpress Genomics
Pioneering a Revolution in Genomic Research: MGI Partners with Xpress Genomics
Pioneering a Revolution in Genomic Research: MGI Partners with Xpress Genomics

Aug 9, 2023

Pioneering a Revolution in Genomic Research: MGI Partners with Xpress Genomics

MGI, a global leader in life science technology, has entered into a strategic partnership with Xpress Genomics, a leading Stockholm-based company specializing in scalable RNA-sequencing strategies. This collaboration seeks to propel the field of genomics into new frontiers, harnessing innovative technologies to develop scalable solutions for deep single-cell RNA-sequencing (scRNA-seq).

Advancing Viral Sequencing: Insights from Teresa Cutino Moguel and MGI's Role
Advancing Viral Sequencing: Insights from Teresa Cutino Moguel and MGI's Role
Advancing Viral Sequencing: Insights from Teresa Cutino Moguel and MGI's Role

Aug 7, 2023

Advancing Viral Sequencing: Insights from Teresa Cutino Moguel and MGI's Role

Teresa Cutino Moguel shares her insights into viral sequencing, its importance in patient care, challenges, and the role of technology at MGI-Tech. She emphasizes the need for accessibility, representation in science, and how collaborations during the pandemic have fostered growth in the field.

The Human Protein Atlas and Precision Medicine: A Conversation with Mathias Uhlen
The Human Protein Atlas and Precision Medicine: A Conversation with Mathias Uhlen
The Human Protein Atlas and Precision Medicine: A Conversation with Mathias Uhlen

Aug 7, 2023

The Human Protein Atlas and Precision Medicine: A Conversation with Mathias Uhlen

Delve into Mathias Uhlen's journey with the Human Protein Atlas, uncovering the potential of precision medicine to transform healthcare, backed by groundbreaking research and technological advancements.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.